Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma.
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma. J Immunother Cancer. 2021 09; 9(9).
View in:
PubMed
subject areas
Chemokine CXCL10
Female
Humans
Immunotherapy
Male
Melanoma
Tumor Microenvironment
authors with profiles
Thomas Gajewski